PhD, FRPharmS
Orest has more than 35 years of product development experience, covering both small and large molecules, including novel ocular drug delivery systems, within the pharmaceutical industry. Prior to joining IACTA, Orest was the Senior Vice President of Global Pharmaceutical Sciences at Allergan, Inc. He also held positions at Johnson & Johnson, CooperVision, and Fisons.
Orest has contributed to well over 30 regulatory submissions, representing a successfully strong track record for product approvals worldwide, with a predominant emphasis in ophthalmology. He was also a pivotal contributor and inventor covering numerous marketed products including those used in the treatment of glaucoma and dry eye.
Orest is a fellow of the Royal Pharmaceutical Society of Great Britain. He received his Ph.D. from the University of Nottingham, UK and his B.Sc. (Hons) in Pharmacy from the Sunderland School of Pharmacy, UK.
He has held academic positions, most recently as visiting professor at the Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Scotland.
